Haemonetics Corp. (HAE)

Sector:Health Care
Super Investor Stats:
Ownership count:0
Ownership rank:--
% of all portfolios:0%
History Portfolio Manager Activity Share change % change to portfolio
Q2  2024
Lee Ainslie - Maverick Capital Sell 100.00% 6,074 0.01
Q1  2024
Lee Ainslie - Maverick Capital Buy 6,074 0.01
Q2  2020
Lee Ainslie - Maverick Capital Sell 100.00% 3,463 0.01
Q1  2020
Lee Ainslie - Maverick Capital Reduce 62.39% 5,744 0.02
Q4  2019
Lee Ainslie - Maverick Capital Buy 9,207 0.02
Q3  2019
Lee Ainslie - Maverick Capital Sell 100.00% 89,560 0.16
Q2  2019
Lee Ainslie - Maverick Capital Buy 89,560 0.16
Q4  2018
Lee Ainslie - Maverick Capital Sell 100.00% 20,830 0.03
Q3  2018
Lee Ainslie - Maverick Capital Buy 20,830 0.03
Q2  2014
Robert Olstein - Olstein Capital Management Sell 100.00% 11,000 0.06
Q1  2014
Meridian Contrarian Fund Sell 100.00% 279,700 1.59
Robert Olstein - Olstein Capital Management Buy 11,000 0.06
Q4  2013
Meridian Contrarian Fund Reduce 21.14% 75,000 0.43
Q3  2013
Meridian Contrarian Fund Reduce 19.29% 84,800 0.48
Q2  2013
Meridian Contrarian Fund Add 12.55% 49,000 0.30
Q1  2013
Meridian Contrarian Fund Add 10.12% 35,900 0.22
Q3  2012
Meridian Contrarian Fund Add 21.86% 63,600 0.40
Q2  2012
Meridian Contrarian Fund Buy 291,000 1.70

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.